Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolff

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based reviewDenise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
European Child & Adolescent Psychiatry|March 22, 2018
Diagnostic accuracy of the ADOS and ADOS-2 in clinical practiceI Kamp-Becker, K Albertowski, J Becker, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based reviewDenise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
European Child & Adolescent Psychiatry|March 22, 2018
Diagnostic accuracy of the ADOS and ADOS-2 in clinical practiceI Kamp-Becker, K Albertowski, J Becker, et al.
Pageof 18